[PDF] Top 20 Um estudo de caso sobre uma possibilidade para o ensino de Matemática na EJA juvenilizada
Has 10000 "Um estudo de caso sobre uma possibilidade para o ensino de Matemática na EJA juvenilizada" found on our website. Below are the top 20 most common "Um estudo de caso sobre uma possibilidade para o ensino de Matemática na EJA juvenilizada".
Synergy of radiotherapy and PD-1 blockade in Kras-mutant lung cancer
... (prostate cancer) to examine synergistic effects of RT and immunother- apy, specifically granulocyte/macrophage colony-stimulating factor-secreting cellular immunotherapy ...with KRAS-driven NSCLC, as our ... See full document
22
Cerebral vasculitis mimicking intracranial metastatic progression of lung cancer during PD-1 blockade
... tween cancer progression and irAE, in particular if the irAE is rare and the likelihood of cancer progression is ...to PD-1/PD-L1 blockade is a very uncommon but severe ...by ... See full document
31
A study of PD-L1 expression in KRAS mutant non-small cell lung cancer cell lines exposed to relevant targeted treatments.
... of KRAS mutant cell lines relatively rapidly and ...of PD-L1, which are the more significant elements when we consider potential biological func- tion and resistance ...suring PD-L1 in the ... See full document
88
Targeting adhesion signaling in KRAS, LKB1 mutant lung adenocarcinoma
... human lung adenocarcinoma, after TP53, and it is inactivated in up to 30% of KRAS mutant non–small cell lung cancers (NSCLC) ...of Kras mutant lung cancer and ... See full document
69
Combined targeting of EGFR/HER promotes anti-tumor efficacy in subsets of KRAS mutant lung cancer resistant to single EGFR blockade
... oncogenic KRAS requires EGF stimulation for enhanced activity in pancreatic cancer cells: EGF induced a prolonged activity of oncogenic KRAS, whereas only transient effects are seen in cells with ... See full document
41
Oncogenic RAS Signaling Promotes Tumor Immunoresistance by Stabilizing PD-L1 mRNA.
... cell-intrinsic PD-L1 expression, implying that mutant RAS oncogenes can directly contribute to the evasion of immune destruction in ...of PD-L1, at least in part, by modulating the stability of the ... See full document
136
Local and abscopal responses in advanced intrahepatic cholangiocarcinoma with low TMB, MSS, pMMR and negative PD-L1 expression following combined therapy of SBRT with PD-1 blockade
... chemotherapy, radiotherapy (RT) or radiochemotherapy do not show satisfactory responses ...ing PD-1/PD-L1 has achieved encouraging therapeutic effects in diverse cancers, and NCCN guidelines ... See full document
11
PD-1 blockade attenuates immunosuppressive myeloid cells due to inhibition of CD47/SIRP aaxis in HPV negative head and neck squamous cell carcinoma
... of PD-1/PD-L1 with MDSCs and TAMs ...of PD-1, PD-L1 in HNSCC correlated with accumulation of MDSCs and TAMs in human and mouse ...expected, PD-1 blockade ... See full document
5
PD-1 blockade restores impaired function of ex vivo expanded CD8<sup>+</sup> T cells and enhances apoptosis in mismatch repair deficient EpCAM<sup>+</sup>PD-L1<sup>+</sup> cancer cells
... Background: Adoptive T cell therapy has been proven to be a promising modality for the treatment of cancer patients in recent years. However, the increased expression of inhibitory receptors could negatively ... See full document
21
<p>Anlotinib Exerts Anti-Cancer Effects on KRAS-Mutated Lung Cancer Cell Through Suppressing the MEK/ERK Pathway</p>
... in lung cancer and especially prevalent in ...in KRAS constitutively activate its downstream signaling pathways 6 such as MEK/ERK, a mitogen-activated protein kinase (MAPK) pathway, this is known to ... See full document
22
Genetic and pharmacologic inhibition of EPHA2 promotes apoptosis in NSCLC
... Genome-wide analyses determined previously that the receptor tyrosine kinase (RTK) EPHA2 is commonly overexpressed in non–small cell lung cancers (NSCLCs). EPHA2 overexpression is associated with poor clin- ical ... See full document
434
Targeting PD-1/PD-L1 in lung cancer: current perspectives
... positive PD-L1 tumors in 40%–50% of NSCLC ...use 1% as a cut-off, but most also test other cut-off points for defining “negative”, “light positive”, and “intense positive” patients (over a cut-off of 50% of ... See full document
16
<p>Resistance Mechanism of PD-1/PD-L1 Blockade in the Cancer-Immunity Cycle</p>
... the PD-1/PD-L1 axis blockade has become a very promising therapy with signi fi cant clinical bene fi ts for multiple tumor ...to PD-1/PD-L1 targeted ...of PD-1 ... See full document
8
In situ mutation detection and visualization of intratumor heterogeneity for cancer research and diagnostics
... the mutant allele was increased in more poorly differentiated glandular areas, both in absolute numbers and relative to the wild-type allele ...from lung cancers, of which two were known to be positive for ... See full document
28
Perspectives in melanoma: Meeting report from the Melanoma Bridge (30 November–2 December, 2017, Naples, Italy)
... Metastatic melanoma represents a challenging clinical situation and, until relatively recently, there was an absence of effective treatment options. However, in 2011, the advanced melanoma treatment landscape was ... See full document
5
Combination of host immune metabolic biomarkers for the PD-1 blockade cancer immunotherapy
... assess PD-L1 expression, we performed PD-L1 IHC using the PD-L1 IHC 22C3 pharmDx kit (Agilent Technologies) as previously described ...tumor PD-L1 expression frequency. PD-L1 TPS was ... See full document
9
Induction of T Cell Immunity Overcomes Resistance to Pd-1 and Ctla-4 Blockade and Improves Survival in Pancreatic Cancer
... of PD-1 and PD-L1 in the KPC tumor microenvironment, I chose to test our hypothesis using the αPD-1 ...Neither PD-1 alone nor αCD40/chemotherapy significantly improved overall ... See full document
11
Inactivation of ABL kinases suppresses non–small cell lung cancer metastasis
... human lung cancer, we evaluated ABL1 and ABL2 protein abundance in 5 pairs of available NSCLC tumors and corre- sponding normal lung ...in lung AC and SCC tumors compared with adjacent nor- ... See full document
12
O GlcNAcylation is required for mutant KRAS induced lung tumorigenesis
... 978 cancer cell lines from many different representative types of cancers resulted in the clear identification of a mesenchymal subset of cancer ...mesenchymal cancer cell lines were composed of ... See full document
92
Niclosamide, an antihelmintic drug, enhances efficacy of PD-1/PD-L1 immune checkpoint blockade in non-small cell lung cancer
... of 1 × 10 6 /well in 6-well plates and then co-cultured with tumor cells pre-treated with niclosamide at 4:1 ratio for 24 ...Anti-human PD- L1 antibody, atezolizumab (Selleck Chemicals, USA) (50 ... See full document
6
Related subjects